https://papzimeos.com/
PAPZIMEOS (zopapogene imadenovec-drba) | Official Patient Site
Apr 7, 2026 - PAPZIMEOS is the first and only FDA-approved immunotherapy to treat recurrent respiratory papillomatosis (RRP) in adults. See Important Safety Information.
patient sitepapzimeosdrbaofficial